Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schoemaker Kathleen K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   8,715,548    

Indirect Shares

   3,038,103      
Direct Value   $235,240,146    

Indirect Value

   $11,280,270      
Total Shares   11,753,651      
Total Value   $246,520,416      


Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $234,144,203 Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $234,144,203
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 29,887 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 2014-02-12 2,972,678 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 9,058 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-01-16 3,590,931 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-04 44,034 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 2,068,960 2015-06-30 0    Premium*  
* Premium Members only  

Records found :    282         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2010-10-06 4 A $0.00 $0 I/I 25,000 25,000 0 -
ZGNX Zogenix, Inc. 10% Owner   –       –       •   2010-11-29 4 A $0.00 $0 I/I 4,252,587 106 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 A $0.00 $0 I/I 18,864 18,864 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2011-11-21 4 A $0.00 $0 I/I 2,110,267 35,388 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2012-05-31 4 A $0.00 $0 I/I 93,434 93,434 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 A $0.00 $0 I/I 2,244,125 16,529 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 A $0.00 $0 I/I 66,462 159,896 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 A $0.00 $0 I/I 1,816,474 30,462 0 -
TBRA Tobira Therapeutics Inc 10% Owner   –       –       •   2013-08-27 4 A $0.00 $0 I/I 1,800,109 14,920 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2013-09-30 4 A $0.00 $0 I/I 1,133,333 19,006 0 -
VCYT Veracyte, Inc. 10% Owner   –       –       •   2013-11-04 4 A $0.00 $0 I/I 3,086,024 22,730 0 -
TNDM Tandem Diabetes Care Inc 10% Owner   –       –       •   2013-11-19 4 A $0.00 $0 I/I 3,243,448 54,390 0 -
DRNA Dicerna Pharmaceuticals I... 10% Owner   –       –       •   2014-02-04 4 A $0.00 $0 I/I 1,765,711 13,004 0 -
AKAO Achaogen Inc 10% Owner   –       –       •   2014-03-17 4 A $0.00 $0 I/I 2,020,939 33,890 0 -
GKOS Glaukos Corp 10% Owner   –       –       •   2015-06-30 4 A $0.00 $0 D/D 2,057,190 2,057,190 0 -
GKOS Glaukos Corp 10% Owner   –       –       •   2015-06-30 4 A $0.00 $0 D/D 14,041 14,041 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-17 4 AS $5.35 $208,131 D/D (38,903) 8,393,338 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-17 4 AS $5.35 $67,490 D/D (12,615) 2,721,425 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-17 4 AS $5.35 $2,236 D/D (418) 89,951 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-17 4 AS $5.35 $1,145 D/D (214) 46,420 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-18 4 AS $5.19 $1,682 D/D (324) 46,096 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-18 4 AS $5.19 $99,025 D/D (19,080) 2,702,345 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-18 4 AS $5.19 $3,275 D/D (631) 89,320 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-18 4 AS $5.19 $305,369 D/D (58,838) 8,334,500 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-22 4 AS $5.02 $75,129 D/D (14,966) 2,687,379 0 -
  282  Records found
  1   2  3   4   5   6   7   8   9   10   11   12      
  Page 2 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us